Categories Retail, Technology

Amazon’s Prime Day sales in jeopardy as European workers plan massive boycott

Only a few days ahead of Amazon’s (AMZN) marquee event, the Prime Day, various European workers’ unions as well as Spanish employees have called for a massive strike, alleging the poor working conditions at its warehouses. While the workers are planning to stage a walkout on Prime Day, which is scheduled for July 16, the unions have launched campaigns asking customers to boycott the company and its products till safe working environments are established.

The employees have petitioned workers at all European warehouses to join the strike, according to a report by Observer. Employees in Poland, Italy, Germany, England, and France are expected to participate in the mass boycott.

https://twitter.com/maclharris/status/1016658448048672773

RELATED: Amazon pumps in $200 million for new distribution center

It may be noted that Prime Day is Amazon’s biggest sale day of the year, which even surpasses Black Friday sales. The event, which is known for its tantalizing offers and flash sales, had in 2017 reported sales of 34 million products.

Amazon has been in the soup for some time over “unhealthy” working conditions at its warehouses. Numerous reports have emerged of the e-commerce giant keeping a strict tab on employees’ loo breaks, increasing working hours as well as giving unattainable goals.

In a response given to Observer, an Amazon spokesperson has denied these allegations, stating “We don’t recognize these allegations as an accurate portrayal of activities in our buildings.”

RELATED: Oops! Amazon accidentally reveals Prime Day schedule

Though it is unlikely that the strike will have any significant impact on Amazon’s profits, with rampant social media campaigning and the inclusion of customers into the issue, the workers may manage to create a slight dent.         

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top